Truist analyst Joon Lee lowered the firm’s price target on Praxis Precision (PRAX) to $85 from $175 and keeps a Buy rating on the shares.

Use of GLP-1 receptor agonists to treat type 2 diabetes is not associated with an increased risk of suicidality compared with ...

A study comparing GLP-1 users to others on antidiabetic drugs showed no added risk once confounders were accounted for.

The judge expressed doubt that the beach volleyball team would stand up to class certification in the Title IX class action ...

Adolescents who are treatment-naive had promising results when using dolutegravir/lamivudine as antiretroviral therapy over ...

Actuate Therapeutics (ACTU) announced the completion of patient enrollment in the ongoing Phase 2 trial of FOLFIRINOX in combination with ...

Pediatric obesity, specifically obesity class II but not class I, was associated with an increased risk for multiple sclerosis.

A study highlighted the accuracy of three leading continuous glucose monitors (CGM), including systems from Abbott and Dexcom ...

SGLT2 inhibitors were associated with better cardioprotective effects among older adults than younger adults with type 2 diabetes.

Owens Corning Roofing and Asphalt, LLC is entitled to summary judgment on the Title VII discrimination and retaliation claims of a Black forklift operator who alleged his supervisor intentionally ...

Mepolizumab reduces asthma exacerbations among real-world patients with severe asthma and an eosinophilic phenotype.